NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 872 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,045,863 | +7.8% | 9,824 | -2.0% | 0.04% | +5.6% |
Q1 2024 | $970,008 | -5.2% | 10,028 | -1.1% | 0.04% | -12.2% |
Q4 2023 | $1,023,735 | -5.1% | 10,139 | -4.2% | 0.04% | -12.8% |
Q3 2023 | $1,078,392 | -0.8% | 10,587 | -1.8% | 0.05% | +6.8% |
Q2 2023 | $1,087,608 | +3.8% | 10,778 | -5.4% | 0.04% | +4.8% |
Q1 2023 | $1,047,788 | +104994.1% | 11,389 | +3.6% | 0.04% | -2.3% |
Q4 2022 | $997 | -99.9% | 10,995 | +2.0% | 0.04% | +13.2% |
Q3 2022 | $820,000 | +3.7% | 10,784 | +15.2% | 0.04% | +8.6% |
Q2 2022 | $791,000 | -5.5% | 9,361 | -1.8% | 0.04% | +12.9% |
Q1 2022 | $837,000 | +11.7% | 9,537 | +11.3% | 0.03% | +19.2% |
Q4 2021 | $749,000 | +25.7% | 8,566 | +17.5% | 0.03% | +8.3% |
Q3 2021 | $596,000 | -11.3% | 7,289 | -1.1% | 0.02% | -11.1% |
Q2 2021 | $672,000 | -41.3% | 7,368 | -44.9% | 0.03% | -47.1% |
Q1 2021 | $1,144,000 | -13.6% | 13,378 | -4.6% | 0.05% | -20.3% |
Q4 2020 | $1,324,000 | +13.8% | 14,017 | +4.8% | 0.06% | 0.0% |
Q3 2020 | $1,163,000 | -8.8% | 13,378 | -8.4% | 0.06% | -11.1% |
Q2 2020 | $1,275,000 | +20.3% | 14,597 | +13.5% | 0.07% | +1.4% |
Q1 2020 | $1,060,000 | +18.8% | 12,860 | +36.6% | 0.07% | +47.9% |
Q4 2019 | $892,000 | +83.5% | 9,417 | +68.3% | 0.05% | +71.4% |
Q3 2019 | $486,000 | +3.4% | 5,594 | +8.7% | 0.03% | 0.0% |
Q2 2019 | $470,000 | -7.1% | 5,148 | -2.1% | 0.03% | -15.2% |
Q1 2019 | $506,000 | +14.2% | 5,259 | +1.8% | 0.03% | +13.8% |
Q4 2018 | $443,000 | -20.2% | 5,168 | -19.7% | 0.03% | -9.4% |
Q3 2018 | $555,000 | -6.4% | 6,438 | -17.9% | 0.03% | -11.1% |
Q2 2018 | $593,000 | -87.2% | 7,845 | -86.3% | 0.04% | -74.5% |
Q1 2018 | $4,642,000 | +54.5% | 57,404 | +60.4% | 0.14% | -19.9% |
Q4 2017 | $3,005,000 | -5.8% | 35,794 | -3.7% | 0.18% | -9.7% |
Q3 2017 | $3,189,000 | +12.8% | 37,151 | +9.7% | 0.20% | +10.2% |
Q2 2017 | $2,827,000 | +11.8% | 33,868 | -0.5% | 0.18% | +9.3% |
Q1 2017 | $2,529,000 | +3.1% | 34,054 | +1.1% | 0.16% | -1.8% |
Q4 2016 | $2,453,000 | -33.7% | 33,682 | -28.1% | 0.16% | -34.8% |
Q3 2016 | $3,698,000 | -4.4% | 46,839 | -0.1% | 0.25% | -6.3% |
Q2 2016 | $3,868,000 | +13.4% | 46,878 | -0.4% | 0.27% | +7.6% |
Q1 2016 | $3,411,000 | -10.0% | 47,088 | +6.8% | 0.25% | -16.1% |
Q4 2015 | $3,792,000 | -4.8% | 44,074 | +1.7% | 0.30% | -9.7% |
Q3 2015 | $3,984,000 | -3.0% | 43,347 | +3.7% | 0.33% | +1.2% |
Q2 2015 | $4,109,000 | -0.8% | 41,783 | -0.5% | 0.33% | -1.2% |
Q1 2015 | $4,142,000 | +6.0% | 42,002 | -0.4% | 0.33% | +0.9% |
Q4 2014 | $3,907,000 | -1.2% | 42,170 | +0.4% | 0.33% | -9.4% |
Q3 2014 | $3,953,000 | +2.1% | 41,997 | -1.7% | 0.36% | 0.0% |
Q2 2014 | $3,870,000 | +12.8% | 42,745 | +5.9% | 0.36% | +2.3% |
Q1 2014 | $3,430,000 | +8.5% | 40,345 | +2.6% | 0.35% | +2.9% |
Q4 2013 | $3,161,000 | +9.8% | 39,329 | +4.7% | 0.34% | 0.0% |
Q3 2013 | $2,880,000 | -10.7% | 37,550 | -17.7% | 0.34% | -11.8% |
Q2 2013 | $3,226,000 | – | 45,619 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |